Cargando…

Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)

BACKGROUND: Vasopressin (AVP) is commonly added to norepinephrine (NE) to reverse shock in patients with sepsis. However, there are no data to support the appropriate strategy of vasopressor tapering in patients on concomitant NE and AVP who are recovering from septic shock. Therefore, the objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Kyeongman, Song, Jae-Uk, Chung, Chi Ryang, Yang, Jeong Hoon, Suh, Gee Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961479/
https://www.ncbi.nlm.nih.gov/pubmed/29784057
http://dx.doi.org/10.1186/s13054-018-2034-9
_version_ 1783324725350498304
author Jeon, Kyeongman
Song, Jae-Uk
Chung, Chi Ryang
Yang, Jeong Hoon
Suh, Gee Young
author_facet Jeon, Kyeongman
Song, Jae-Uk
Chung, Chi Ryang
Yang, Jeong Hoon
Suh, Gee Young
author_sort Jeon, Kyeongman
collection PubMed
description BACKGROUND: Vasopressin (AVP) is commonly added to norepinephrine (NE) to reverse shock in patients with sepsis. However, there are no data to support the appropriate strategy of vasopressor tapering in patients on concomitant NE and AVP who are recovering from septic shock. Therefore, the objective of this study was to evaluate the incidence of hypotension while tapering vasopressors in patients on concomitant NE and AVP recovering from septic shock. METHODS: Patients with septic shock receiving concomitant NE and AVP were randomly assigned to taper NE first (NE group) or AVP first (AVP group). The primary end point was the incidence of hypotension within one hour of tapering of the first vasopressor. We also evaluated the association between serum copeptin levels and the occurrence of hypotension. RESULTS: The study was stopped early due to a significant difference in the incidence of hypotension after 38 and 40 patients were enrolled in the NE group and the AVP group, respectively. There were 26 patients (68.4%) in the NE group versus 9 patients (22.5%) in the AVP group who developed hypotension after tapering the first vasopressor (p < 0.001). There was a similar finding during the subsequent tapering of the second vasopressor (64.5% in the NE vs 25.0% in the AVP group, p = 0.020). Finally, NE tapering was significantly associated with hypotension during the study period (hazard ratio, 2.221; 95% confidence interval, 1.106–4.460; p = 0.025). The serum copeptin level was lower in patients in whom hypotension developed during tapering of AVP than it was in those without hypotension. CONCLUSIONS: Tapering NE rather than AVP may be associated with a higher incidence of hypotension in patients recovering from septic shock who are on concomitant NE and AVP. However, further studies with larger sample sizes are required to better determine the appropriate strategy for vasopressor tapering. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01493102. Registered on 15 December 2011.
format Online
Article
Text
id pubmed-5961479
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59614792018-06-25 Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS) Jeon, Kyeongman Song, Jae-Uk Chung, Chi Ryang Yang, Jeong Hoon Suh, Gee Young Crit Care Research BACKGROUND: Vasopressin (AVP) is commonly added to norepinephrine (NE) to reverse shock in patients with sepsis. However, there are no data to support the appropriate strategy of vasopressor tapering in patients on concomitant NE and AVP who are recovering from septic shock. Therefore, the objective of this study was to evaluate the incidence of hypotension while tapering vasopressors in patients on concomitant NE and AVP recovering from septic shock. METHODS: Patients with septic shock receiving concomitant NE and AVP were randomly assigned to taper NE first (NE group) or AVP first (AVP group). The primary end point was the incidence of hypotension within one hour of tapering of the first vasopressor. We also evaluated the association between serum copeptin levels and the occurrence of hypotension. RESULTS: The study was stopped early due to a significant difference in the incidence of hypotension after 38 and 40 patients were enrolled in the NE group and the AVP group, respectively. There were 26 patients (68.4%) in the NE group versus 9 patients (22.5%) in the AVP group who developed hypotension after tapering the first vasopressor (p < 0.001). There was a similar finding during the subsequent tapering of the second vasopressor (64.5% in the NE vs 25.0% in the AVP group, p = 0.020). Finally, NE tapering was significantly associated with hypotension during the study period (hazard ratio, 2.221; 95% confidence interval, 1.106–4.460; p = 0.025). The serum copeptin level was lower in patients in whom hypotension developed during tapering of AVP than it was in those without hypotension. CONCLUSIONS: Tapering NE rather than AVP may be associated with a higher incidence of hypotension in patients recovering from septic shock who are on concomitant NE and AVP. However, further studies with larger sample sizes are required to better determine the appropriate strategy for vasopressor tapering. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01493102. Registered on 15 December 2011. BioMed Central 2018-05-21 /pmc/articles/PMC5961479/ /pubmed/29784057 http://dx.doi.org/10.1186/s13054-018-2034-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jeon, Kyeongman
Song, Jae-Uk
Chung, Chi Ryang
Yang, Jeong Hoon
Suh, Gee Young
Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
title Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
title_full Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
title_fullStr Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
title_full_unstemmed Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
title_short Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
title_sort incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (dovss)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961479/
https://www.ncbi.nlm.nih.gov/pubmed/29784057
http://dx.doi.org/10.1186/s13054-018-2034-9
work_keys_str_mv AT jeonkyeongman incidenceofhypotensionaccordingtothediscontinuationorderofvasopressorsinthemanagementofsepticshockaprospectiverandomizedtrialdovss
AT songjaeuk incidenceofhypotensionaccordingtothediscontinuationorderofvasopressorsinthemanagementofsepticshockaprospectiverandomizedtrialdovss
AT chungchiryang incidenceofhypotensionaccordingtothediscontinuationorderofvasopressorsinthemanagementofsepticshockaprospectiverandomizedtrialdovss
AT yangjeonghoon incidenceofhypotensionaccordingtothediscontinuationorderofvasopressorsinthemanagementofsepticshockaprospectiverandomizedtrialdovss
AT suhgeeyoung incidenceofhypotensionaccordingtothediscontinuationorderofvasopressorsinthemanagementofsepticshockaprospectiverandomizedtrialdovss